The Role of Decavanadate in Anti- Tumour Activity
Open Access
- 11 March 2017
- journal article
- Published by Peertechz Publications Private Limited in Global Journal of Cancer Therapy
- Vol. 3 (1), 012-014
- https://doi.org/10.17352/gjct.000015
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Inhibitory effects of decavanadate on several enzymes and Leishmania tarentolae In VitroJournal of Inorganic Biochemistry, 2012
- Polyoxometalates as potent and selective inhibitors of alkaline phosphatases with profound anticancer and amoebicidal activitiesDalton Transactions, 2012
- Discovery of polyoxometalate-based HDAC inhibitors with profound anticancer activity in vitro and in vivoEuropean Journal of Medicinal Chemistry, 2011
- Effects of decavanadate and insulin enhancing vanadium compounds on glucose uptake in isolated rat adipocytesJournal of Inorganic Biochemistry, 2009
- Decavanadate: a journey in a search of a roleDalton Transactions, 2009
- Decavanadate (V10O6−28) and oxovanadates: Oxometalates with many biological activitiesJournal of Inorganic Biochemistry, 2009
- Antitumour effect of polyoxomolybdates: induction of apoptotic cell death and autophagy in in vitro and in vivo modelsBritish Journal of Cancer, 2007
- Anti-tumor, -viral, and -bacterial activities of polyoxometalates for realizing an inorganic drugJournal of Materials Chemistry, 2005
- A novel anti-tumor agent, polyoxomolybdate induces apoptotic cell death in AsPC-1 human pancreatic cancer cellsBiomedicine & Pharmacotherapy, 2005
- Polyoxometalates in MedicineChemical Reviews, 1998